Home LiteratureArticle Details
PMID: 3542924 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Elimination of plasmids by enoxacin and ofloxacin at near inhibitory concentrations.

The Journal of antimicrobial chemotherapy ·Vol. 18 ·No. 5 ·1986-11-00 ·Pages 575-83

Weisser J, Wiedemann B

Abstract

The abilities of the 4-quinolones enoxacin and ofloxacin, inhibitors of DNA gyrase subunit A, to eliminate plasmids from Escherichia coli have been studied in a narrow concentration range just below the MIC. These compounds cured most efficiently at the highest concentration which still allows cell growth and produced 20% to 100% plasmid-free cells, depending upon the plasmid tested. Higher concentrations were required to eliminate plasmids from a gyrANalr strain, consistent with their higher MICs, but maximal curing frequencies were similar to those obtained with the Nals strain. Kinetics of plasmid elimination indicated that plasmid loss occurred by inhibition of plasmid replication, which seems to be somewhat more sensitive to the action of 4-quinolones than chromosome replication. Low or high curing frequencies with a given curing agent seem to be a property of the plasmid tested.

MeSH Terms
Enoxacin Escherichia coli/drug effects,genetics Kinetics Naphthyridines/pharmacology Ofloxacin Oxazines/pharmacology Plasmids/drug effects
Chemicals
Naphthyridines Oxazines Enoxacin Ofloxacin
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Weisser J
Wiedemann B
Article Info
Journal
The Journal of antimicrobial chemotherapy
Abbr.
J Antimicrob Chemother
ISSN
0305-7453
Published
1986-11-00
Pages
575-83
Language
English
Region
England
NLM ID
7513617
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]